Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 Covid-19 Pandemic Publisher



Farhoudian A1 ; Radfar SR2, 3 ; Ardabili HM4, 5 ; Rafei P6, 7 ; Ebrahimi M7 ; Zonoozi AK5 ; De Jong CAJ8 ; Vahidi M1 ; Yunesian M9 ; Kouimtsidis C10 ; Arunogiri S11 ; Hansen H12 ; Brady KT13 ; Potenza MN14 Show All Authors
Authors
  1. Farhoudian A1
  2. Radfar SR2, 3
  3. Ardabili HM4, 5
  4. Rafei P6, 7
  5. Ebrahimi M7
  6. Zonoozi AK5
  7. De Jong CAJ8
  8. Vahidi M1
  9. Yunesian M9
  10. Kouimtsidis C10
  11. Arunogiri S11
  12. Hansen H12
  13. Brady KT13
  14. Potenza MN14
  15. Baldacchino AM15
  16. Ekhtiari H16
  17. Abagiu AO17
  18. Abouna FDN18
  19. Ahmed MH19
  20. Alansari B20
  21. Alkhair FMA21
  22. Almaqbali MH22
  23. Ambekar A23
  24. Arya S24
  25. Asebikan VO25
  26. Ayasreh MA26
  27. Basu D27
  28. Benmebarek Z28
  29. Bhad R23
  30. Blaise M29
  31. Bonnet N30
  32. Brasch J31
  33. Broers B32
  34. Busse A33
  35. Butner JL34
  36. Camilleri M35
  37. Campello G33
  38. Carra G36
  39. Celic I37
  40. Chalabianloo F38
  41. Chaturvedi A39
  42. Cherpitel JJEN40
  43. Clark KJ41
  44. Cyders MA42
  45. De Bernardis E43
  46. Deilamizade A44
  47. Derry JE45
  48. Dhagudu NK46
  49. Dolezalova P47
  50. Dom G48
  51. Dunlop AJ49
  52. Elhabiby MM50
  53. Elkholy H51
  54. Essien NF52
  55. Farah GI53
  56. Ferri M54
  57. Floros GD55
  58. Friedman C56
  59. Fuderanan CH57
  60. Gerra G33
  61. Ghosh A58
  62. Gogia M59
  63. Grammatikopoulos IA60
  64. Grandinetti P61
  65. Guirguis A62
  66. Gutnisky D63
  67. Haber PS64
  68. Hassaniabharian P65
  69. Hooshyari Z66
  70. Ibrahim IIM50
  71. Ieong HFH67
  72. Indradewi RN68
  73. Iskandar S69
  74. Isra TN70
  75. Jain S71
  76. James S72
  77. Javadi SMH73
  78. Joe KH74
  79. Jokubonis D75
  80. Jovanova AT76
  81. Kamal RM77
  82. Kantchelov AI78
  83. Kathiresan P23
  84. Katzman G79
  85. Kawale P80
  86. Kern AM81
  87. Kessler FHP82
  88. Kim SGS83
  89. Kimball AM84
  90. Kljucevic Z85
  91. Kurniasanti KS86
  92. Lev R87
  93. Lee HK88
  94. Lengvenyte A89
  95. Levran S90
  96. Mabelya GS91
  97. Mahi MAE92
  98. Maphisa JM93
  99. Maremmani I94
  100. Masferrer L95
  101. Massah O96
  102. Mccambridge O97
  103. Mcgovern GG98
  104. Min AK99
  105. Moghanibashimansourieh A73
  106. Morarios J100
  107. Mudalige IUK101
  108. Mukherjee D102
  109. Munira PM103
  110. Myers B104
  111. Menon T N J105
  112. Narasimha VL106
  113. Ndionuka N107
  114. Nejatisafa AA108
  115. Niaz K33
  116. Nizami AT109
  117. Nuijens JH110
  118. Orsolini L111
  119. Oum V112
  120. Oyemade AA113
  121. Palavra IR114
  122. Pant SB115
  123. Paredes J116
  124. Peyron E117
  125. Quiros RA118
  126. Qurishi R119
  127. Rafiq NUZ120
  128. Raghavendra Rao R121
  129. Rattaapha W122
  130. Raymond KL123
  131. Reimer J124
  132. Renaldo E125
  133. Rezapour T126
  134. Robertson JR127
  135. Roncero C128
  136. Roub F129
  137. Rubenstein EJ130
  138. Rupp CI131
  139. Saenz E33
  140. Salehi M132
  141. Samartzis L133
  142. Sarubbo LB134
  143. Segrec N135
  144. Shah B136
  145. Shen H137
  146. Shirasaka T138
  147. Shoptaw S139
  148. Sintango FM140
  149. Sosa VA141
  150. Subata E75
  151. Sztycberg N142
  152. Taghizadeh F143
  153. Wee Teck JBT144
  154. Tjagvad C145
  155. Torrens M146
  156. Twala JM147
  157. Vadivel R148
  158. Volpicelli JR149
  159. Weijs J150
  160. Wintoniw SM151
  161. Wittayanookulluk A152
  162. Wojnar M153
  163. Yasir S109
  164. Yitayih Y154
  165. Zhao M155

Source: Frontiers in Psychiatry Published:2021


Abstract

Background and Aims: COVID-19 has infected more than 77 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing, and “lockdown” measures have affected drug and alcohol supply chains and subsequently their availability, price, and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic. Design: Cross-sectional survey. Setting: Worldwide. Participants: Starting on April 4, 2020 during a 5-week period, the survey received 185 responses from 77 countries. Measurements: To assess addiction medicine professionals' perceived changes in drug and alcohol supply, price, use pattern, and related complications during the COVID-19 pandemic. Findings: Participants reported (among who answered “decreased” or “increased”) a decrease in drug supply (69.0%) and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported, while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall. Conclusions: The global report on changes in the availability, use patterns, and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to people with SUD. © Copyright © 2021 Farhoudian, Radfar, Mohaddes Ardabili, Rafei, Ebrahimi, Khojasteh Zonoozi, De Jong, Vahidi, Yunesian, Kouimtsidis, Arunogiri, Hansen, Brady, ISAM Global Survey Consortium (ISAM-GSC), Potenza, Baldacchino and Ekhtiari.
Other Related Docs
12. Population Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (2015-2016), International Journal of Health Policy and Management (2023)